Thomson Angus W, Turnquist Hēth R, Raimondi Giorgio
Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Nat Rev Immunol. 2009 May;9(5):324-37. doi: 10.1038/nri2546.
The potent immunosuppressive action of rapamycin is commonly ascribed to inhibition of growth factor-induced T cell proliferation. However, it is now evident that the serine/threonine protein kinase mammalian target of rapamycin (mTOR) has an important role in the modulation of both innate and adaptive immune responses. mTOR regulates diverse functions of professional antigen-presenting cells, such as dendritic cells (DCs), and has important roles in the activation of effector T cells and the function and proliferation of regulatory T cells. In this Review, we discuss our current understanding of the mTOR pathway and the consequences of mTOR inhibition, both in DCs and T cells, including new data on the regulation of forkhead box P3 expression.
雷帕霉素强大的免疫抑制作用通常归因于其对生长因子诱导的T细胞增殖的抑制。然而,现在很明显,丝氨酸/苏氨酸蛋白激酶哺乳动物雷帕霉素靶蛋白(mTOR)在先天免疫和适应性免疫反应的调节中都起着重要作用。mTOR调节专业抗原呈递细胞(如树突状细胞,DC)的多种功能,并在效应T细胞的激活以及调节性T细胞的功能和增殖中发挥重要作用。在本综述中,我们讨论了我们目前对mTOR通路的理解以及mTOR抑制在DC和T细胞中的后果,包括关于叉头框P3表达调节的新数据。